NCT03814655 (DIGIMPLGD) is a NA clinical trial of Full digital workflow in Partially Edentulous Maxilla, sponsored by Concordia Dent Srl.

Who is sponsoring NCT03814655?

NCT03814655 is sponsored by Concordia Dent Srl.

What drugs are being tested in NCT03814655?

Interventions in NCT03814655: Full digital workflow, Partially digital workflow.

What condition does NCT03814655 study?

NCT03814655 studies Partially Edentulous Maxilla, Partially Edentulous Mandible.

Is NCT03814655 still recruiting?

NCT03814655 is currently completed. Last updated 14 July 2020.

Last reviewed 2020-07-14 · How we verify

NCT03814655: DIGIMPLGD

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of the Accuracy of Full Digital Workflow for Guided Implant Surgery Using the R2 Gate Software

Completed NA Last updated 14 July 2020

What this trial tests

NA trial testing Full digital workflow in Partially Edentulous Maxilla in 54 participants. Completed in 13 July 2020.

Timeline

1 July 2019

Primary endpoint
15 February 2020

13 July 2020

Quick facts

Lead sponsor	Concordia Dent Srl
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	54
Start date	1 July 2019
Primary completion	15 February 2020
Estimated completion	13 July 2020
Sites	2 locations across Romania

Drugs / interventions tested

Full digital workflow
Partially digital workflow

Conditions studied

Partially Edentulous Maxilla — all drugs for Partially Edentulous Maxilla →
Partially Edentulous Mandible — all drugs for Partially Edentulous Mandible →

Sponsor

Concordia Dent Srl — full company profile →

Who can join

Adults 18 to 99, any sex, with Partially Edentulous Maxilla or Partially Edentulous Mandible. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary aim of the present study is to compare the accuracy of a full digital workflow for dental implants insertion to a partially digital workflow, for a limited edentulous space (1 to 3 dental units), in the maxilla or mandible.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Accuracy, Labor-Time and Patient-Reported Outcomes with Partially versus Fully Digital Workflow for Flapless Guided Dental Implants Insertion-A Randomized Clinical Trial with One-Year Follow-Up.
Cristache CM, Burlibasa M, Tudor I, Totu EE, et al · · 2021 · cited 15× · PMID 33800946 · DOI 10.3390/jcm10051102

Verify or expand the search:

Other Concordia Dent Srl trials

Trials by the same sponsor.

NCT03656484 — New Periodontitis Treatment Based on Hyaluronic Acid and Melatonin · Phase 2 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03814655 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Concordia Dent Srl
Last refreshed: 14 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03814655.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing